Davita Inc (NYSE:DVA) VP Leanne M. Zumwalt sold 949 shares of the firm’s stock in a transaction on Friday, December 8th. The stock was sold at an average price of $68.19, for a total value of $64,712.31. Following the transaction, the vice president now owns 12,423 shares in the company, valued at $847,124.37. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Shares of Davita Inc (DVA) traded up $0.89 during trading hours on Tuesday, hitting $70.40. The stock had a trading volume of 2,538,900 shares, compared to its average volume of 1,661,123. Davita Inc has a twelve month low of $52.51 and a twelve month high of $70.58. The stock has a market cap of $12,814.77, a P/E ratio of 19.35, a PEG ratio of 13.65 and a beta of 0.97. The company has a debt-to-equity ratio of 1.79, a current ratio of 1.40 and a quick ratio of 1.35.
Davita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, November 7th. The company reported $0.81 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.94 by ($0.13). Davita had a net margin of 3.40% and a return on equity of 13.31%. The company had revenue of $3.92 billion during the quarter, compared to analysts’ expectations of $3.91 billion. During the same quarter in the prior year, the business posted $0.95 earnings per share. The company’s revenue was up 5.2% compared to the same quarter last year. sell-side analysts forecast that Davita Inc will post 3.42 EPS for the current fiscal year.
DVA has been the topic of several research reports. Royal Bank of Canada restated a “hold” rating and set a $64.00 price objective on shares of Davita in a report on Wednesday, September 6th. J P Morgan Chase & Co downgraded Davita from a “neutral” rating to an “underweight” rating in a report on Monday, October 9th. Raymond James Financial upgraded Davita from an “outperform” rating to a “strong-buy” rating and raised their price objective for the stock from $65.00 to $84.00 in a report on Thursday, December 7th. Robert W. Baird restated a “hold” rating and set a $63.00 price objective on shares of Davita in a report on Friday, November 10th. Finally, SunTrust Banks set a $57.00 price objective on Davita and gave the stock a “hold” rating in a report on Sunday, October 15th. Three investment analysts have rated the stock with a sell rating, five have given a hold rating, three have given a buy rating and two have assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $73.33.
Large investors have recently made changes to their positions in the company. Rhumbline Advisers boosted its position in shares of Davita by 4.4% in the 3rd quarter. Rhumbline Advisers now owns 321,155 shares of the company’s stock worth $19,073,000 after purchasing an additional 13,471 shares in the last quarter. Riverhead Capital Management LLC boosted its position in shares of Davita by 10.6% in the 2nd quarter. Riverhead Capital Management LLC now owns 112,506 shares of the company’s stock worth $7,286,000 after purchasing an additional 10,775 shares in the last quarter. Founders Capital Management LLC boosted its position in shares of Davita by 2.3% in the 3rd quarter. Founders Capital Management LLC now owns 95,939 shares of the company’s stock worth $5,698,000 after purchasing an additional 2,115 shares in the last quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH boosted its position in shares of Davita by 1,987.3% in the 3rd quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH now owns 41,746 shares of the company’s stock worth $2,448,000 after purchasing an additional 39,746 shares in the last quarter. Finally, Speece Thorson Capital Group Inc. boosted its position in shares of Davita by 14.5% in the 3rd quarter. Speece Thorson Capital Group Inc. now owns 321,182 shares of the company’s stock worth $19,075,000 after purchasing an additional 40,667 shares in the last quarter. Institutional investors and hedge funds own 85.32% of the company’s stock.
DaVita Inc, formerly DaVita HealthCare Partners Inc, operates two divisions: DaVita Kidney Care (Kidney Care) and DaVita Medical Group (DMG). The Kidney Care division consists of its the United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support.
What are top analysts saying about Davita? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Davita and related companies.